Modular, Single-Use Facilities Increase Biomanufacturing Flexibility

Source: Sartorius
Sartorius-Logo-350 wide

The pipelines of biopharmaceutical companies are becoming increasingly diverse while improvements in cell lines are leading to more productive bioprocesses. These factors are driving new capacity demands for biopharmaceutical companies and their CDMO partners. It is becoming increasingly important, therefore, that companies implement Innovative, highly efficient, flexible facilities that are capable of meeting these challenging capacity demands.

New Biomanufacturing Facilities must meet the following requirements

  • Apply single-use technologies for lower capital expenditures (CAPEX), from cell vial to drug product vial and from development to routine manufacturing
  • Provide a platform for rapid transition between product development and commercialization
  • Ensure rapid start-up and ease of compliance – Be reusable and flexible as process and products change (New manufacturing strategies)
  • Allow process transfers readily
  • Allow the development of automation and control strategies, including PAT, data analysis, real-time release
  • Allow security of supply (single-source vs. multiple sourcing)
access the Poster!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online